Genprex宣布澳大利亚知识产权局拟授予Reqorsa®基因疗法联合PD-L1抗体治疗癌症专利

美股速递
Feb 10

Genprex公司今日披露,澳大利亚知识产权局已表达授予其专利的意向,该专利涵盖其研发的Reqorsa®基因疗法与PD-L1抗体联合使用的治疗方案,旨在攻克多种癌症。这一重要进展标志着公司在肿瘤治疗领域的创新技术获得国际权威认可,为后续临床开发与商业化奠定坚实基础。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10